-
641
Measuring Measuring iron concentration in the blood samples of some autistic children from Baghdad City
Published 2025-01-01“…Iron is one of the heavy metals around which there is much controversy regarding their role as neurotoxins in the development of autism, its excess in the brain may cause Alzheimer's disease or Parkinson's disease, while iron deficiency in the blood may increase levels of other heavy metals in the blood and brain, such as cadmium and lead. …”
Get full text
Article -
642
Procedural Memory: Computer Learning in Control Subjects and in Parkinson’s Disease Patients
Published 1996-01-01“…We also studied 24 patients with Parkinson's disease (PD). We observed an influence of age and also of educational levels. …”
Get full text
Article -
643
Cannabis oil in treating Parkinson’s disease: improvement of motor and non-motor symptoms: a case report
Published 2025-01-01“…These compelling results suggest that cannabis oil may offer a valuable and effective therapeutic option for individuals with Parkinson's disease.…”
Get full text
Article -
644
EFFECT OF Zanthoxylum acanthopodium DC EXTRACT ON THE INCREASE OF BRAIN CELLS IN THE SUBSTANTIA NIGRA OF WISTAR RATS THAT ARE ROTENONE-INDUCED
Published 2024-12-01“… Parkinson's disease (PD) is a neurodegenerative disorder due to the decline of dopaminergic neurons in the substantia nigra, with motor and non-motor symptoms. …”
Get full text
Article -
645
Multicomponent reactions driving the discovery and optimization of agents targeting central nervous system pathologies
Published 2024-12-01“…In this review, we focus on central nervous system (CNS) disorders, particularly Alzheimer's disease, Parkinson's disease, schizophrenia, depression, and epilepsy, where MCRs have contributed to the development of promising ligands in recent years. …”
Get full text
Article -
646
Microglia-secreted TNF-α affects differentiation efficiency and viability of pluripotent stem cell-derived human dopaminergic precursors.
Published 2023-01-01“…Finally, Tumour necrosis factor alpha plays a key role in these effects, suggesting that this cytokine could be an interesting target to increase the efficacy of human dopaminergic precursors transplantation in Parkinson's Disease.…”
Get full text
Article -
647
Decision Making under Risk Condition in Patients with Parkinson’s Disease: A Behavioural and fMRI Study
Published 2010-01-01“…We aimed to study whether previously described impairment in decision making under risky conditions in patients with Parkinson's disease (PD) is affected by deficits in using information about potential incentives or by processing feedback (in terms of fictitious gains and losses following each decision). …”
Get full text
Article -
648
More than just a number: the gut microbiota and brain function across the extremes of life
Published 2024-12-01“…In neurodegeneration research, strong causal evidence now links the gut microbiome to Alzheimer's (AD), and Parkinson's Disease (PD), as supported by human-to-animal transplantation studies. …”
Get full text
Article -
649
Dendrobium species regulate energy homeostasis in neurodegenerative diseases: a review
Published 2023-11-01“…Furthermore, they reduce neurotoxicity, alleviate brain injury and neuropathy, and prevent neurodegenerative conditions including stroke, Alzheimer's disease, Parkinson's disease, and Huntington's disease in humans and/or rodents. …”
Get full text
Article -
650
Applications of Ultrasonic Brain Imaging and Transcranial Ultrasound Therapy in Brain Injury Rehabilitation
Published 2023-04-01“…High intensity focused ultrasound (HIFU) and low intensity focused ultrasound (LIFU) use the thermal and mechanical effects respectively to perform tissue ablation, blood-brain barrier opening, drug targeted delivery, ultrasound-assisted catheter-directed thrombolysis and neuromodulation, and can be applied to the treatment of brain tumors, brain trauma, stroke, Parkinson's disease, Alzheimer's disease, epilepsy, depression and other neurological diseases and mental diseases. …”
Get full text
Article -
651
Superfoods and their impact on brain health: a systematic review
Published 2025-01-01“…Abstract Aim of the study This review examines the pharmacology and clinical applications of superfoods like Crocus sativus, Murraya koenigii, Phoenix dactylifera, Punica granatum, Ficus carica, and Beta vulgaris on mental health, anxiety, depression, schizophrenia, Alzheimer's disease, cognitive decline, psychosis, Parkinson's disease, and stroke. We hope this perspective guides superfood research. …”
Get full text
Article -
652
Diet and medical foods in Parkinson’s disease
Published 2019-06-01“…Parkinson's disease (PD) is a slowly progressive neurodegenerative disorder with motor and non-motor signs, which begins long before the diagnosis can be made. …”
Get full text
Article -
653
Hippocampal Proliferation Is Increased in Presymptomatic Parkinson’s Disease and due to Microglia
Published 2014-01-01“…Besides dopamine-deficiency related motor symptoms, nonmotor symptoms, including cognitive changes occur in Parkinson's disease (PD) patients, that may relate to accumulation of α-synuclein in the hippocampus (HC). …”
Get full text
Article -
654
Remission of Cognitive Deficits in Parkinson’s Disease: Recovery from a Nonamnestic Mild Cognitive Impairment or Psychiatric Symptoms Remission?
Published 2012-01-01“…Mild cognitive impairment is a clinical condition more frequent in patients with Parkinson's disease than in general population. The nonamnestic presentations, usually characterized by executive dysfunction, are most prevalent. …”
Get full text
Article -
655
Dietary L-proline supplementation ameliorates autism-like behaviors and modulates gut microbiota in the valproic acid-induced mouse model of autism spectrum disorder
Published 2024-09-01“…RNA sequencing demonstrated that Pro can also alter the PFC transcriptomic profile distinguished by the regulation of genes involved in Parkinson disease, neuroactive ligand-receptor interaction, oxidative phosphorylation, and mitogen activated protein kinase signaling pathway. …”
Get full text
Article -
656
Alpha synuclein overexpression can drive microbiome dysbiosis in mice
Published 2025-02-01“…Abstract Growing evidence indicates that persons with Parkinson disease (PD), have a unique composition of indigenous gut microbes. …”
Get full text
Article -
657
The Effects of Multimodal Exercise Program on Functional Capacity and Quality of Life in Elderly Patients with Parkinson\'s Disease
Published 2024-12-01“…Introduction: Parkinson's disease (PD) is a degenerative neurological illness characterized by various motor and non-motor symptoms that can lead to varying degrees of functional impairment. …”
Get full text
Article -
658
CASE REPORT ON TWO CONSECUTIVE PATIENTS WITH NEUROINVASIVE WEST NILE VIRUS INFECTION IN AN INTENSIVE CARE UNIT
Published 2025-01-01“…The first case was a 60-year-old man who have had mental status changes, fever, and progression of existing Parkinson's disease. Antibodies to WNV were present in cerebrospinal fluid (CSF). …”
Get full text
Article -
659
Therapeutic potential of phytocompounds of Bacopa monnieri (L.) Wettst (literature review)
Published 2024-10-01“…Numerous clinical trials show the effectiveness of the use of extracts in the treatment of anhedonia, depression, Alzheimer's disease, Parkinson's disease, dementia and hyperactivity. An analysis of clinical studies in Ukraine shows that drugs based on B. monnieri can be used in the complex treatment of cognitive impairment associated with dyscirculatory encephalopathy in adults and perinatal CNS damage in children. …”
Get full text
Article -
660
New perspectives on the glymphatic system and the relationship between glymphatic system and neurodegenerative diseases
Published 2025-02-01“…It discusses the potential roles of the glymphatic system in ND, including Alzheimer's disease (AD), Parkinson's disease (PD), and multiple system atrophy (MSA), and proposes the glymphatic system as a novel therapeutic target for these conditions.…”
Get full text
Article